Long Read Sequencing Market to be dominated by Rising Incidences of Genetic Disorders through 2027

Growing R&D activities and rising government support to drive the long read sequencing market in the forecast period, 2023-2027.

According to TechSci Research report, “Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027”, the global long read sequencing market is anticipated to grow at a significant rate in the forecast period, 2023-2027. The growing occurrences of genetic disorders, the growing government support for R&D activities, and increase in adoption of advanced technologies are the primary factors driving the demand for the global long read sequencing market. The growing number of patients with cancer, rise in R&D activities, rising popularity of personalized medicine, growing favorable government funding, increasing healthcare expenditure, and growing adoption of inorganic growth strategies are expected to influence the market demand. Also, the rising utilization of sequence analysis methodologies in medical institutes for academic purposes are also a key factor for increasing the growth of the long read sequencing market, globally.

However, the lack of high complexity genomic testing centers in high potential markets, challenges pertaining to genomic data centers, and scarcity of knowledge dissemination pertaining to advanced diagnostic capabilities may hamper the growth of the global Long Read Sequencing market.

Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Long Read Sequencing Market"

The global long read sequencing market is segmented into component, technology, workflow, application, end user, and company.

Based on component, the market is divided into instruments, consumables, and services. The consumables segment is anticipated to grow during the forecast period. This is attributed to the users that perform genome sequencing buy it frequently.

Based on technology, the market is divided into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. The single-molecule real-time sequencing (SMRT) segment is anticipated to grow during the forecast period. This is attributed to the low systematic bias leading to achieving high consensus accuracy, and its longer read lengths.

Based on workflow, the market is divided into pre-sequencing, sequencing, and data analysis. The sequencing segment is anticipated to grow during the forecast period. This is attributed to the rapid advancement in technology, and rise in occurrences of genetic disorders

Based on application, the market is divided into oncology, infectious diseases, rare diseases, genetic disorders, metabolic disorders, and others. The Infectious disease segment is anticipated to grow during the forecast period. This is attributed to the growing incidences of infectious diseases, large patient pool, growing awareness, and rising demand for early detection to identify the origin of disease and in making of an antidote.

Based on end user, the market is divided into hospitals & clinics, biotechnology & pharmaceutical companies, academic & research institutions, and others. The academic & research institutions segment is anticipated to grow during the forecast period. This is attributed to the presence of numerous biotechnology research centers, academic workshops, and the rising use of sequence analysis approaches in research.

Major companies operating in global long read sequencing market are:

• Agilent Technologies, Inc.
• BGI Group
• Bionano Genomics, Inc.
• Circulomics Inc
• Oxford Nanopore Technologies plc
• Longas Technologies Pty Ltd
• Novogene Co., Ltd.
• Illumina, Inc.
• F. Hoffmann-La Roche AG
• Pacific Biosciences of California, Inc.
• Quantapore, Inc.
• QIAGEN NV
• PerkinElmer, Inc
• Thermo Fischer Scientific, Inc.
• Takara Bio, Inc.

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America region dominates the market in 2021 and is expected to maintain its dominance in the coming years due to adoption of the latest technology and rising utilization of long-read sequencing techniques across medical diagnostic centers. The upsurge in research and development activities, the availability of strong reimbursement policies from public and private health insurance firms, favorable government initiatives in the healthcare sector, and growing academic and clinical use of genomic techniques in the region are expected to propel the global long read sequencing market growth till 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

“Long Read Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Component (Instruments, Consumables, Services), By Technology (Single-Molecule Real-Time Sequencing (SMRT), Nanopore Sequencing, Others), By Workflow (Pre-Sequencing, Sequencing, Data Analysis), By Application (Oncology, Infectious Diseases, Rare Diseases, Genetic Disorders, Metabolic Disorders, Others), By End User (Hospitals & Clinics, Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others), By Region, By company and By Region”, has evaluated the future growth potential of global long read sequencing market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global long read sequencing market.

Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com